What this covers

James P. Allison, a Nobel laureate immunologist at MD Anderson Cancer Center, discusses with host Sean Carroll how the immune system's T cells can be harnessed to eliminate cancer. The conversation centers on a counterintuitive discovery: rather than developing drugs that directly attack tumors, the most durable approach is to disable molecular brakes on T cells, allowing the body's own cellular defenses to find and destroy cancer wherever it has spread. Allison recounts how his lab identified CTLA-4 not as an activator but as a checkpoint that halts T-cell expansion, and how blocking it—later combined with blocking PD-1—transformed metastatic melanoma from an almost uniformly fatal disease into one where more than half of patients are cured with lasting protection.

The episode ranges across the mechanisms tumors use to hide from immune attack: losing MHC presentation of mutated proteins, acquiring mutations that disable interferon signaling, and exploiting myeloid cells that mistake tumors for wounds requiring repair. Allison explains why the Two-Signal Model of T Cell Activation leaves solid tumors invisible unless their cell death first primes the innate immune system, and why the immune system treats both driver and passenger mutations as threats without distinguishing between them. He also addresses why evolution has left bodies poorly defended against cancer—because natural selection ends after reproduction—and touches on emerging evidence that similar immune mechanisms may underlie neurodegenerative diseases, suggesting therapies developed for cancer could one day address Alzheimer's and Parkinson's by working in reverse.

Sharpest takeaway

Allison argues that because the immune system's T cells naturally surveil the body for anything 'not self,' the most durable way to fight cancer is not to attack tumors directly but to release the molecular brakes (checkpoints) on T cells so the body's own cells eliminate cancer wherever it has spread, conferring lasting protection.

  • Tumors evade T cells via mechanisms like losing MHC presentation and exploiting myeloid cells that treat tumors like wounds
  • Blocking the CTLA-4 brake (and later PD-1) lets T cells expand long enough to destroy tumors, curing a large fraction of metastatic melanoma patients
  • The real 'drug' is the T cell, which persists for life, unlike conventional chemo/radiation that must kill every cell

The argument · threads1 threads · 33 claims
0.85

Large animals get cancer less often despite having more cells, a paradox whose mechanism is not yet understood.

1 pointcentrality 5/5
  • There is an apparent paradox that larger animals, which have more cells and might be expected to get cancer more easily, in fact get it more rarely—elephants, for instance, do not seem to get cancer often—though the mechanism is not understood and could partly reflect lower carcinogen exposure.

    “larger animals, you might expect to get cancer more easily 'cause there's more cells, but in fact they get it more rarely.”